169 related articles for article (PubMed ID: 4077313)
1. Effect of ZnSO4 upon gastric acid secretion and carbonic anhydrase.
Puscas I; Sturzu L; Búzás G
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):609-12. PubMed ID: 4077313
[TBL] [Abstract][Full Text] [Related]
2. Effects of the synthetic PGE1 derivative misoprostol on basal, stimulated and nocturnal acid secretion in duodenal ulcer cases. Mechanism of action.
Buzás G; Puscas I; Persa F; Reznicek A
Acta Physiol Hung; 1989; 73(2-3):185-91. PubMed ID: 2512765
[TBL] [Abstract][Full Text] [Related]
3. Effect of verapamil on purified bovine carbonic anhydrase. An in vitro study.
Puscas I; Búzás G; Sturzu L; Vălean S
Arzneimittelforschung; 1984; 34(9):946-7. PubMed ID: 6542373
[TBL] [Abstract][Full Text] [Related]
4. Treatment of duodenal ulcers with ethoxzolamide, an inhibitor of gastric mucosa carbonic anhydrase.
Puscas I; Buzas G
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):97-9. PubMed ID: 3957499
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gastric mucosa carbonic anhydrase by pirenzepine in patients with gastroduodenal ulcers.
Puşcaş I; Búzás G; Surányi P; Domuta M
Arzneimittelforschung; 1981; 31(3):508-9. PubMed ID: 6894381
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole has a dual mechanism of action: it inhibits both H(+)K(+)ATPase and gastric mucosa carbonic anhydrase enzyme in humans (in vitro and in vivo experiments).
Puscas I; Coltau M; Baican M; Domuta G
J Pharmacol Exp Ther; 1999 Aug; 290(2):530-4. PubMed ID: 10411559
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: antisecretory and cytoprotective properties.
Puscas I; Buzás G; Puscas JC; Persa F
Acta Physiol Hung; 1989; 73(2-3):167-77. PubMed ID: 2512764
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of carbonic anhydrase by pirenzepin].
Puşcaş I; Búzás G; Surányi P; Domuţa M; Simonca M; Arcălean O
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(1):65-8. PubMed ID: 6114536
[No Abstract] [Full Text] [Related]
9. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin activates carbonic anhydrase and antagonizes the effect of the specific carbonic anhydrase inhibitor acetazolamide, by a direct mechanism of action.
Puscas I; Ifrim M; Maghiar T; Coltau M; Domuta G; Baican M; Hecht A
Int J Clin Pharmacol Ther; 2001 Jun; 39(6):265-70. PubMed ID: 11430635
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of carbonic anhydrase by pirenzepine.
Puşcaş I; Búzás G; Surányi P; Domuta M
Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):75-7. PubMed ID: 6783555
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandins with vasodilating effects inhibit carbonic anhydrase while vasoconstrictive prostaglandins and leukotriens B4 and C4 increase CA activity.
Puscas I; Coltau M
Int J Clin Pharmacol Ther; 1995 Mar; 33(3):176-81. PubMed ID: 7599917
[TBL] [Abstract][Full Text] [Related]
13. Activation of carbonic anhydrase by beta-adrenergic agonists and inhibition by beta-adrenergic blockers.
Puşcas I; Reznicek A; Moldovan A; Puşcaş C; Sturzu L
Med Interne; 1985; 23(3):185-9. PubMed ID: 2864736
[TBL] [Abstract][Full Text] [Related]
14. Cysteamine, the most potent ulcerogenic drug known so far, powerfully activates carbonic anhydrase I, II and IV. In vitro and in vivo studies.
Puscas I; Coltau M; Maghiar A; Domuta G
Exp Toxicol Pathol; 2000 Oct; 52(5):431-5. PubMed ID: 11089894
[TBL] [Abstract][Full Text] [Related]
15. [Interrelationships of histamine, erythrocytic carbonic anhydrase and gastric acid secretion].
Puşcaş I; Tudoran L; Contrasiu P; Surany P; Domuţa M
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(6):555-8. PubMed ID: 44759
[No Abstract] [Full Text] [Related]
16. A new concept regarding the mechanism of action of omeprazole.
Puscas I; Coltau M; Baican M; Domuta G
Int J Clin Pharmacol Ther; 1999 Jun; 37(6):286-93. PubMed ID: 10395120
[TBL] [Abstract][Full Text] [Related]
17. Serum zinc level : a possible index in the pathogenesis of peptic ulcer syndrome.
Bandyopadhyay B; Banerjee P; Bhattacharya B; Bandyopadhyay SK
Biochem Mol Biol Int; 1995 Aug; 36(5):965-72. PubMed ID: 7581013
[TBL] [Abstract][Full Text] [Related]
18. Study of the damaging effects of acetazolamide on gastric mucosa in rats.
Cho CH; Pfeiffer CJ
Acta Physiol Hung; 1984; 64(3-4):279-85. PubMed ID: 6442531
[TBL] [Abstract][Full Text] [Related]
19. "Ulcosilvanil"--an inhibitor of carbonic anhydrase--associated with adrenergic beta-blockers in the treatment of duodenal ulcers.
Puşcaş I; Reznicek A; Búzás G; Milaş D; Kovács E; Sturzu D; Perşa F; Nemeş-Brateş R; Vălean S
Med Interne; 1986; 24(1):75-9. PubMed ID: 3704506
[TBL] [Abstract][Full Text] [Related]
20. Luminal acid in water-immersion stress and the antiulcer effect of axetazolamide in the rat gastric mucosa.
Gutierrez-Cabano CA
Acta Gastroenterol Latinoam; 1999; 29(1):25-31. PubMed ID: 10435191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
